China has highest PD-1/PD-L1 combination immuno-oncology therapies clinical trials growth: GlobalData Read more
FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1 diabetes space Read more
Successive drug launches will drive growth of NASH market in seven major markets: GlobalData Read more